A case report that detailed the removal of a cyst from the side of a young woman’s face has been retracted for plagiarizing text from a similar case report published two years earlier.
When two papers include the same images of rat hearts, one of those papers gets retracted.
The papers share a corresponding author, Zhi-Qing Zhao of Mercer University School of Medicine in Savannah, Georgia. This marks his third retraction; we reported on two others earlier this year.
This accepted manuscript has been retracted because the journal is unable to verify reviewer identities.
Sounds like another case of faked emails to generate fake peer reviews, right? But that’s not what happened to this paper, according to the editor in chief of Antimicrobial Agents and Chemotherapy, Louis B. Rice, a professor at Brown University:
Science is fixing images in a paper published online in April that discovered an immune-boosting protein, after the authors mistakenly mixed up similar-looking Western blots.
This is exciting because we have found a completely different way to use the immune system to fight cancer.
The editor in chief of Science,Marcia McNutt, told us that the journal contacted the authors once it learned of “irregularities” in some of the figures, which did not affect the conclusions of the paper:
A group of computer scientists has a pair of retractions for duplicating “substantial parts” of other articles written by different authors. Both papers, published in Neural Computing and Applications, are on ways to screen for breast cancer more effectively.
According to the abstract of “An improved data mining technique for classification and detection of breast cancer from mammograms,” computers make the process of identifying cancer in lesions detected by mammograms faster and more accurate:
Although general rules for the differentiation between benign and malignant breast lesion exist, only 15–30% of masses referred for surgical biopsy are actually malignant. Physician experience of detecting breast cancer can be assisted by using some computerized feature extraction and classification algorithms. Computer-aided classification system was used to help in diagnosing abnormalities faster than traditional screening program without the drawback attribute to human factors.
The article has been cited four times, according to Thomson Scientific’s Web of Knowledge. The retraction note reveals where “substantial parts” of the article came from:
Chronic fatigue syndrome researcher Judy Mikovits was scheduled to head is heading to court today, where a California judge will would decide whether or not to dismiss her lawsuit against fourteen people and two Nevada corporations.
(Note: This story has been updated. See below.)
Among the defendants: the Whittemore Peterson Institute in Reno, Nevada where Mikovits used to work; the institute’s cofounders, Annette and Harvey Whittemore; a colleague with whom she shares a retracted Science paper; and several members of California and Nevada law enforcement.
The complaint does not check the box next to “Money Demanded in Complaint”, but also lists $750,000 in the associated field:
What are the specific health benefits to skipping out on meat? We’re not totally sure, after the largest organization for nutrition professionals pulled its 2015 position statement on this issue only weeks after publishing it in the Journal of the Academy of Nutrition and Dietetics.
The authors of a paper on an anti-fungal bacterium couldn’t ward off a very common problem: plagiarism. The people credited on the paper, published in Applied Microbiology and Biotechnology, apparently weren’t the original authors, according to the retraction note.
We’re not sure who the original authors are. The retraction note doesn’t elaborate much:
Following questions about the veracity of multiple papers by his former employer, high-profile social psychologist Jens Förster has agreed to retract two papers as part of a deal with the German Society for Psychology (DGPs).
Just two of those papers are acknowledged in the settlement of a case by the DGPs against Förster, who currently works at Ruhr University Bochum. Here’s a translation of a notice from the DGPs from One Hour Translation:
Sometimes, the path to correcting the scientific record takes a few turns. In the case of a paper about a new cancer compound, authorship issues led to a correction and, ultimately, a retraction — along with a double-back to retract the earlier correction.
We reported on the first part of the story back in January: A 2011 paper that described a novel compound that could work as a drug for the side effects of chemotherapy was corrected in 2012 to add additional authors. But once the authors realized their supposedly novel compound had actually been synthesized by another author, they decided to retract the paper from Bioorganic and Medicinal Chemistry earlier this year, concluding “these facts made the paper inappropriate and unfaithful.”